Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
4
MRAI Quote, Financials, Valuation and Earnings
Last price:
$0.98
Seasonality move
:
-10.55%
Day range:
$0.98 - $1.09
52-week range:
$0.40 - $2.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
--
Volume:
33.4K
Avg. volume:
35.1K
1-year change:
-47.74%
Market cap:
$10.1M
Revenue:
$37.2M
EPS (TTM):
-$3.06
Analysts' Opinion
-
Consensus RatingMarpai has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Marpai has an estimated downside of -- from its current price of $0.98.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $0.98.
Fair Value
-
According to the consensus of 0 analysts, Marpai has -- downside to fair value with a price target of -- per share.
MRAI vs. S&P 500
-
Over the past 5 trading days, Marpai has underperformed the S&P 500 by -19.81% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Marpai does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Marpai revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Marpai reported revenues of $7.4M.
Earnings Growth
-
Marpai has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Marpai reported earnings per share of -$0.46.
Enterprise value:
9.3M
EV / Invested capital:
--
Price / LTM sales:
0.22x
EV / EBIT:
--
EV / Revenue:
0.27x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.73x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$12.2M
Return On Assets:
-66.07%
Net Income Margin (TTM):
-69.48%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-55.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Income Statement | ||||||
| Revenue | $20.4M | $27.8M | $34.9M | $9.7M | $7.4M | |
| Gross Profit | $5.6M | $8.8M | $12.2M | $3.3M | $2.5M | |
| Operating Income | -$20M | -$29.7M | -$21.9M | -$8.5M | -$4.1M | |
| EBITDA | -$16.9M | -$25.2M | -$17.9M | -$7.2M | -$2.9M | |
| Diluted EPS | -$4.66 | -$5.80 | -$3.06 | -$1.68 | -$0.46 | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $22.9M | $20.1M | $16.5M | |
| Total Assets | -- | -- | $39.6M | $42.2M | $30.1M | |
| Current Liabilities | -- | -- | $12M | $17.5M | $20.1M | |
| Total Liabilities | -- | -- | $15.2M | $44.1M | $44.6M | |
| Total Equity | -- | -- | $24.5M | -$1.9M | -$14.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$13.4M | -$38.5M | -$12.8M | -$6.5M | -$3.6M | |
| Cash From Investing | $9.7M | $32.9M | $1M | $3K | -- | |
| Cash From Financing | $24.9M | $200 | $8.8M | -- | $3.7M | |
| Free Cash Flow | -$15.1M | -$38.5M | -$12.8M | -$6.5M | -$3.6M | |
MRAI
Sector
Market Cap
$10.1M
$694.9M
Price % of 52-Week High
33.14%
87.97%
Dividend Yield
0%
2.23%
Shareholder Yield
-37.59%
3.88%
1-Year Price Total Return
-47.74%
8.55%
Beta (5-Year)
--
0.737
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$1.16
200-day SMA
Sell
Level
$1.18
Bollinger Bands (100)
Buy
Level
0.44 - 1.16
Chaikin Money Flow
Sell
Level
-51.6M
20-day SMA
Sell
Level
$1.32
Relative Strength Index (RSI14)
Sell
Level
40.28
ADX Line
Sell
Level
14.19
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$1.05
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
200.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.0421)
Sell
CA Score
(Annual)
Level (-5.8531)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (10.5001)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients’ health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States.
Stock Forecast FAQ
In the current month, MRAI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MRAI average analyst price target in the past 3 months is --.
-
Where Will Marpai Stock Be In 1 Year?
According to analysts, the consensus estimate is that Marpai share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Marpai?
Analysts are divided on their view about Marpai share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Marpai is a Sell and believe this share price will rise from its current level to --.
-
What Is Marpai's Price Target?
The price target for Marpai over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MRAI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Marpai is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MRAI?
You can purchase shares of Marpai via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Marpai shares.
-
What Is The Marpai Share Price Today?
Marpai was last trading at $0.98 per share. This represents the most recent stock quote for Marpai. Yesterday, Marpai closed at $0.98 per share.
-
How To Buy Marpai Stock Online?
In order to purchase Marpai stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
